Raja Shekar

462 citations
15 papers · 306 indexed · h-index 11
Topics
CNS Lymphoma Diagnosis and Treatment (2 papers)Drug-Induced Adverse Reactions (2 papers)Antimicrobial Resistance in Staphylococcus (2 papers)
Partner nations
United States

In The Last Decade

Raja Shekar

14 papers receiving 295 citations

Peers

Raja Shekar
Comparison fields: 5 of 58
  • Epidemiology 97
  • Infectious Diseases 78
  • Pharmacology 76
  • Surgery 71
  • Public Health, Environmental and Occupational Health 48
Replace Philip W. Lam with:
Philip W. Lam Canada
Carlo Pallotto Italy
François Trémolières France
W Huck United States
Alan R. Salkind United States
Kenta Ito Japan
Ian M. Baird United States
Maryrose Laguio‐Vila United States
Lawrence Eisenstein United States
Guillermo Rodriguez-Gomez United States
Raja Shekar relative to Philip W. Lam Canada Philip W. Lam's profile →
Citations per field
00.5×1.5×1.8×
Philip W. Lam · 1×
Citations per year

Countries citing papers authored by Raja Shekar

Since Specialization
Citations

This map shows the geographic impact of Raja Shekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raja Shekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raja Shekar more than expected).

Fields of papers citing papers by Raja Shekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raja Shekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raja Shekar. The network helps show where Raja Shekar may publish in the future.

Co-authorship network of co-authors of Raja Shekar

This figure shows the co-authorship network connecting the top 25 collaborators of Raja Shekar. A scholar is included among the top collaborators of Raja Shekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raja Shekar. Raja Shekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 2
3 63
4 15
5 66
6 3
7 18
8 10
9 15
10 1
11 21
12 23
13 16
14 14
15 39

About Raja Shekar

Raja Shekar is a scholar working on Microbiology, Parasitology and Infectious Diseases, having authored 15 papers that have together received 306 indexed citations. Recurring topics across this work include CNS Lymphoma Diagnosis and Treatment (2 papers), Drug-Induced Adverse Reactions (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Microbiology (11 citations), Applied Microbiology and Biotechnology (25 citations) and Molecular Medicine (40 citations). Raja Shekar has collaborated with scholars based in United States. Frequent co-authors include Burton C. West, Charles A. Kallick, Thomas W. Rice, Joseph E. Loewenstein, Adi A. Gerblich, Sandeep Grover, John Biddle, S. Bass and John H. Raaf. Their work appears in journals such as Clinical Infectious Diseases, CHEST Journal and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026